Logo

U.S. Antipsychotic Drugs Market Size, Trends, Share, and Growth Forecast, 2026 - 2033

U.S. Antipsychotic Drugs Market by Disease (Schizophrenia, Bipolar Disorder, Others), Therapeutic Class (First Generation, Second Generation, Third Generation), Distribution Channel (Hospital Pharmacies, Others), and Zone Analysis 2026 – 2033

ID: PMRREP34928
Calendar

March 2026

254 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. U.S. Antipsychotic Drugs Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Russia Sectoral Outlook
      2. Russia GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Application Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2025A
    1. Key Highlights
    2. Key Factors Impacting Prices, By Disease
    3. Pricing Analysis, By Disease
    4. Regional Prices and Flavor Preferences
  5. U.S. Antipsychotic Drugs Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2026 – 2033
    3. U.S. Antipsychotic Drugs Market Outlook: Disease
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Disease, 2020 – 2025
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Disease, 2026 – 2033
        1. Schizophrenia
        2. Bipolar Disorder
        3. Others
      4. Market Attractiveness Analysis: Disease
    4. U.S. Antipsychotic Drugs Market Outlook: Therapeutic Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Class, 2020 – 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Class, 2026 – 2033
        1. First Generation
        2. Second Generation
        3. Third Generation
      4. Market Attractiveness Analysis: Therapeutic Class
    5. U.S. Antipsychotic Drugs Market Outlook:Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2020 – 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. 5.5.4 Market Attractiveness Analysis: Distribution Channel
  6. U.S. Antipsychotic Drugs Market Outlook
    1. Key Highlights
    2. Market Attractiveness Analysis
  7. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Otsuka Pharmaceutical Co., Ltd
        1. Overview
        2. Segments and Diseases
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Janssen Pharmaceuticals
      3. AbbVie Inc.
      4. Bristol Myers Squibb
      5. Eli Lilly and Company
      6. Pfizer Inc.
      7. Teva Pharmaceutical Industries Ltd.
      8. Alkermes plc
      9. H. Lundbeck A/S
      10. Sumitomo Pharma
      11. Dr. Reddy’s Laboratories Ltd.
      12. AstraZeneca plc
      13. GlaxoSmithKline plc
      14. Vanda Pharmaceuticals Inc.
      15. Johnson & Johnson
      16. Karuna Therapeutics
  8. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -